Skip to main content
. 2016 Jun 17;7(34):55721–55731. doi: 10.18632/oncotarget.10124

Table 1. Patients characteristics (N=25).

Characteristic No. of Patients %
Age, years
 Median 40
 Range 17 to 64
Sex
 Male 14 56.00
 Female 11 44.00
Subtype of ENKL
 UAT-NTCL 24 96.00
 NUAT-NTCL 1 4.00
Stage at enrollment
 III 17 68.00
 IV 8 32.00
“B” symptoms present 12 48.00
Elevated serum LDH 9 36.00
Performance status
 0 5 20.00
 1 14 56.00
 2 6 24.00
NK/T-cell PI score
 0-1 0 0.00
 2 12 48.00
 3 8 32.00
 4 5 20.00